Comparative physicochemical and biological characterization of the similar imiglucerase product Glurazyme® and the originator product Cerezyme®
A biosimilar considered as a biomolecule medicinal product that is comparable to a reference medicinal product in terms of the structural, functional, biological, and clinical attributes. Glurazyme® was developed as a biosimilar to Cerezyme® (imiglucerase) and was approved in CIS countries (Russian...
Saved in:
| Main Authors: | Maksim Smolov, Serge Taran, Ivan Lyagoskin, Maria Neronova, Maksim Degterev, Rakhim Shukurov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Journal of Pharmaceutical and Biomedical Analysis Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949771X23000245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation and study of adverse reactions to imiglucerase based on the FAERS database
by: Pan Hong, et al.
Published: (2025-08-01) -
Physicochemical and Functional Characterization of Medicinal Product Rinsulin® R
by: A. V. Babina, et al.
Published: (2023-05-01) -
Approaches to resolve practical challenges in the context of assessing the price of biosimilar products
by: A. H.-M. Valeeva, et al.
Published: (2025-01-01) -
Modern Clinical Guidelines for the Management of Patients with Gaucher Disease
by: Inga V. Anisimova, et al.
Published: (2024-12-01) -
On ERT and MERT-Rings
by: Zubayda Ibraheem
Published: (2004-05-01)